Author(s): Belleville S; Anderson ND; Bherer L; Camicioli R; Carrier J; Chan S; Cuesta M; Dang-Vu TT; Dwosh E; Fiocco AJ; Ferland G; Gilbert B; Harris E; Itzhak I; Jarrett P; Kadri MA; Laurin D; Liu-Ambrose T; McGibbon CA; Middleton L; Miller L; Ny ...

Background: Online educational programs focused on ways to improve brain health could increase participant literacy, empowerment, and engagement in activities that support personal brain health, potentially reducing dementia risk. Objectives: Our goal was to develop an evidence-based online educ ...

Article GUID: 40090784

Author(s): Smith EE; Phillips NA; Feldman HH; Borrie M; Ganesh A; Henri-Bhargava A; Desmarais P; Frank A; Badhwar A; Barlow L; Bartha R; Best S; Bethell J; Bhangu J; Black SE; Bocti C; Bronskill SE; Burhan AM; Calon F; Camicioli R; Campbell B; Coll ...

Lecanemab and donanemab are monoclonal antibody therapies that remove amyloid-beta from the brain. They are the first therapies that alter a fundamental mechanism, amyloid-beta deposition, in Alzheimer disease (AD). To inform Canadian decisions on approval and use of these drugs, the Canadian Con ...

Article GUID: 39893139